Mainstay Set To Launch ReActiv8 Neurostimulator In Germany
This article was originally published in Clinica
Executive Summary
Mainstay Medical is ready to launch its ReActiv8 neurostimulator, starting in Germany, now that the implantable device has a CE mark for the treatment of chronic back pain, the company announced May 25.